Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)
China
· Delayed Price · Currency is CNY 8.33
+0.04 (0.48%)
Apr 30, 2026, 1:55 PM CST
SHE:002566 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 2,744 | 2,525 | 2,257 | 2,949 | 2,681 | 2,992 | Upgrade
|
| Market Cap Growth | 15.14% | 11.88% | -23.46% | 10.00% | -10.40% | 35.74% | Upgrade
|
| Enterprise Value | 2,676 | 2,540 | 2,289 | 2,979 | 2,869 | 3,226 | Upgrade
|
| Last Close Price | 8.29 | 7.63 | 6.73 | 8.61 | 7.78 | 8.65 | Upgrade
|
| PE Ratio | 82.43 | 87.08 | 43.33 | 31.13 | 32.26 | 31.16 | Upgrade
|
| Forward PE | - | 49.09 | 49.09 | 49.09 | 49.09 | 49.09 | Upgrade
|
| PS Ratio | 4.16 | 3.94 | 3.38 | 3.45 | 3.23 | 3.41 | Upgrade
|
| PB Ratio | 1.17 | 1.08 | 0.97 | 1.26 | 1.19 | 1.36 | Upgrade
|
| P/TBV Ratio | 1.28 | 1.19 | 1.06 | 1.39 | 1.32 | 1.53 | Upgrade
|
| P/FCF Ratio | 27.19 | 29.67 | 52.49 | 17.01 | 25.66 | 27.69 | Upgrade
|
| P/OCF Ratio | 25.33 | 25.57 | 38.29 | 14.10 | 18.38 | 13.91 | Upgrade
|
| EV/Sales Ratio | 4.06 | 3.97 | 3.42 | 3.49 | 3.46 | 3.67 | Upgrade
|
| EV/EBITDA Ratio | 33.79 | 41.88 | 22.96 | 19.59 | 22.27 | 20.91 | Upgrade
|
| EV/EBIT Ratio | 68.56 | 114.64 | 40.21 | 27.88 | 32.33 | 28.30 | Upgrade
|
| EV/FCF Ratio | 26.52 | 29.85 | 53.23 | 17.18 | 27.46 | 29.86 | Upgrade
|
| Debt / Equity Ratio | 0.20 | 0.19 | 0.19 | 0.20 | 0.20 | 0.19 | Upgrade
|
| Debt / EBITDA Ratio | 7.33 | 6.88 | 4.32 | 3.06 | 3.34 | 2.64 | Upgrade
|
| Debt / FCF Ratio | 4.65 | 5.24 | 10.46 | 2.75 | 4.25 | 3.84 | Upgrade
|
| Net Debt / Equity Ratio | -0.07 | -0.05 | -0.04 | -0.05 | 0.02 | 0.04 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.77 | -2.06 | -0.82 | -0.75 | 0.31 | 0.62 | Upgrade
|
| Net Debt / FCF Ratio | -1.64 | -1.47 | -1.90 | -0.66 | 0.39 | 0.88 | Upgrade
|
| Asset Turnover | 0.22 | 0.22 | 0.22 | 0.28 | 0.28 | 0.31 | Upgrade
|
| Inventory Turnover | 0.11 | 0.11 | 0.11 | 0.14 | 0.14 | 0.14 | Upgrade
|
| Quick Ratio | 2.07 | 2.09 | 2.02 | 1.36 | 1.17 | 1.15 | Upgrade
|
| Current Ratio | 5.86 | 6.24 | 6.49 | 4.12 | 3.92 | 4.16 | Upgrade
|
| Return on Equity (ROE) | 1.41% | 1.24% | 2.17% | 4.20% | 3.97% | 4.83% | Upgrade
|
| Return on Assets (ROA) | 0.46% | 0.47% | 1.18% | 2.22% | 1.90% | 2.52% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.97% | 0.96% | 2.17% | 4.08% | 3.38% | 4.25% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.90% | 0.90% | 2.20% | 4.30% | 3.70% | 4.90% | Upgrade
|
| Earnings Yield | 1.21% | 1.15% | 2.31% | 3.21% | 3.10% | 3.21% | Upgrade
|
| FCF Yield | 3.68% | 3.37% | 1.91% | 5.88% | 3.90% | 3.61% | Upgrade
|
| Dividend Yield | 0.98% | 1.05% | 1.49% | 1.74% | 0.64% | 0.35% | Upgrade
|
| Payout Ratio | 135.25% | 157.27% | 118.33% | 31.52% | - | 24.29% | Upgrade
|
| Buyback Yield / Dilution | 0.03% | -0.04% | 0.03% | -0.02% | 0.02% | -0.01% | Upgrade
|
| Total Shareholder Return | 1.01% | 1.01% | 1.51% | 1.72% | 0.66% | 0.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.